We retrospectively analyzed our 2-year experience with venous access for 363 therapeutic plasma exchanges in 46 patients with neurological disease, including acute Guillain-Barrd syndrome (N = 20). myasthenia gravis (N = 17), and chronic inHammatory demyelinating polyneuropathy (N = 9). Twenty-three
Therapeutic plasma exchange performed in tandem with hemodialysis for patients with M-protein disorders
β Scribed by Aftab Mahmood; Donata Sodano; Anthony Dash; Robert Weinstein
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 94 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
β¦ Synopsis
M-proteins are monoclonal immunoglobulins or immunoglobulin fragments that aberrantly accumulate in the plasma. Hemodialysis (HD) patients with M-proteins may, under certain circumstances, also need therapeutic plasma exchange (TPE). We employed a protocol for tandem TPE/HD in patients with M-protein disorders. We followed the urea reduction ratio (URR), a measure of the efficiency of HD, to compare the effect of TPE on HD efficiency during tandem procedures versus the efficiency of HD performed as a stand-alone procedure in the same patients. Three men (J.M., R.T., M.M.) underwent 23, 80, and 25 tandem TPE/HD over 3, 17, and 7 months, respectively, almost all in the outpatient setting. Mean whole blood flow rate (in ml/min) was slower during hemodialysis alone than during TPE/HD for J.M. (289 Β± 24 vs. 332 Β± 22, P < 0.0001) and R.T. (310 Β± 20 vs. 367 Β± 15, P < 0.0001) but not for M.M. (395 Β± 65 vs. 404 Β± 62, P ΒΌ 0.6844). URR was equivalent during hemodialysis alone and during TPE/HD for J.M. (54 Β± 4.2 vs. 58 Β± 1.4, P ΒΌ 0.3333), R.T. (69 Β± 4.9 vs. 70 Β± 2.5, P ΒΌ 0.9804), and M.M. (71 Β± 2.4 vs. 67 Β± 1.5, P ΒΌ 0.1143). J.M.'s renal function recovered sufficiently to permit discontinuation of hemodialysis. R.T. experienced both subjective and objective improvement of his arthritic symptoms. M.M. achieved hemostatic control but ultimately died of amyloidosis. TPE/HD is feasible using disparate pieces of equipment when the therapeutic plasma exchange circuit is connected in parallel with the low-pressure side of the hemodialysis circuit. Our experience illustrates that therapeutic plasma exchange did not adversely impact hemodialysis when the two procedures were performed in tandem.
π SIMILAR VOLUMES
## Abstract **Background:** Previous reports had emphasized the importance of humoral immunity in heart failure in humans, primarily determined by the presence of circulating antibodies. However, there is little or no information about the frequency of anticardiac antibodies present in failing huma
We report on the feasibility, safety, and efficacy of performing therapeutic plasmapheresis (TPE) in parallel with extracorporeal membrane oxygenation (ECMO) to alleviate antibody mediated rejection (AMR) after heart transplantation. Two pediatric and one adult patient presented with severe congesti
Therapeutic plasma exchange (TPE) is a procedure performed on patients suffering from various disorders, including thrombotic thrombocytopenic purpura (TTP). As we noted a frequent transient deterioration in respiratory function when the procedure was performed on intensive care unit (ICU) patients,